Coronavirus: AstraZeneca defends EU vaccine rollout plan

The head of pharmaceutical company, AstraZeneca has defended its rollout of the coronavirus vaccine in the EU, amid tension with member states over delays in supply.

Pascal Soriot told newsmen that his team was working 24/7 to fix the issues vaccine of production.

He said production was two months behind schedule.

He also hinged the supply delay to European countries to the EU’s late decision to sign contracts.

Mr Soriot, said a contract with the UK had been signed three months before the one with the EU, giving more time for glitches to be ironed out.